INS and fatty liver disease: Concomitantly, obesity, metabolic syndrome and during prediabetes insulin promotes lipogenesis, triglyceridemia and hepatic steatosis and further in the presence of high glucose milieu, insulin actively promotes liver glycogen synthesis and de novo lipogenesis28,29 was in accordance with our data.